GIANT Technology

Revolutionary rapid antimicrobial susceptibility testing platform

Introducing GIANT

GIANT is a breakthrough rapid antimicrobial susceptibility testing (AST) platform designed to transform how healthcare providers diagnose and treat infectious diseases.

Traditional AST methods require 48–72 hours to determine which antibiotics will effectively treat a bacterial infection. During this waiting period, clinicians must rely on empirical treatment, often using broad-spectrum antibiotics that may be ineffective or contribute to resistance development.

GIANT changes this paradigm by delivering comprehensive susceptibility results in hours rather than days, enabling precision medicine approaches that improve patient outcomes while preserving antibiotic efficacy.

GIANT Capabilities

40–60 Hour Faster Results

GIANT delivers comprehensive AST results in hours instead of days, enabling rapid treatment decisions that can significantly improve patient outcomes and reduce hospital stays.

Tests 50+ Antibiotics

Our platform simultaneously tests over 50 different antibiotics, providing clinicians with a complete susceptibility profile in a single assay.

500+ Concentrations

GIANT evaluates more than 500 antibiotic concentrations in one test, delivering precise minimum inhibitory concentration (MIC) data for optimal dosing decisions.

Why It Matters

Rapid AST results translate directly into improved patient care and healthcare system efficiency.

Patient Survival

Every hour counts in severe infections. By reducing time to effective treatment, GIANT helps improve survival rates, especially in cases of sepsis and bloodstream infections where delays can be fatal.

Reduced Hospital Stays

Faster identification of effective antibiotics means patients can transition from intravenous to oral therapy sooner, reducing length of stay and freeing up critical hospital resources.

Lower Healthcare Costs

By enabling targeted treatment and shorter hospital stays, GIANT helps reduce overall healthcare costs. Avoiding ineffective antibiotics and complications saves both money and resources.

Preserving Antibiotic Efficacy

Precision treatment reduces unnecessary broad-spectrum antibiotic use, helping preserve the effectiveness of these critical drugs for future patients and combating resistance development.